ImmunityBio (IBRX) Accounts Payables (2014 - 2026)
ImmunityBio's (IBRX) quarterly Accounts Payables came in at $500000.0 in Q1 2026, up 150.0% year-on-year from $200000.0 in Q1 2025, and down 92.83% on a QoQ basis from $7.0 million in Q4 2025.
ImmunityBio (IBRX) Accounts Payables (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Accounts Payables data on file, last reported at $500000.0 in Q1 2026.
- On a quarterly basis, Accounts Payables rose 150.0% year-over-year to $500000.0 in Q1 2026; TTM through Mar 2026 was $500000.0, a 150.0% increase from a year earlier, with the FY2025 full-year figure at $7.0 million, up 3933.53% from the prior year.
- Accounts Payables for Q1 2026 stood at $500000.0, down from $7.0 million in the prior quarter.
- Over the last five years, Accounts Payables for IBRX reached as high as $33.6 million in Q1 2023 and fell as low as $37000.0 in Q2 2023.
- Historically, Accounts Payables has averaged $5.7 million across 5 years, with a median of $267500.0 in 2024.
- Across the five-year window, Accounts Payables plunged 99.8% in 2023 and soared 3933.53% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $986000.0 in 2022, then tumbled by 86.21% to $136000.0 in 2023, then advanced by 27.21% to $173000.0 in 2024, then surged by 3933.53% to $7.0 million in 2025, then tumbled by 92.83% to $500000.0 in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $500000.0 in Q1 2026, $7.0 million in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 6.98 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 235,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Dec 31, 2023 | 136,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 37,000.00 |
| Mar 31, 2023 | 33.57 Mn |
| Dec 31, 2022 | 986,000.00 |
| Sep 30, 2022 | 20.24 Mn |
| Jun 30, 2022 | 18.05 Mn |
| Mar 31, 2022 | 9.83 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | 15.12 Mn |
| Jun 30, 2021 | 19.15 Mn |
| Mar 31, 2021 | 20.10 Mn |